Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
Jing Liu, Sheng Liu, Zhao Zhang, et al.
Synthetic and Systems Biotechnology (2021) Vol. 6, Iss. 3, pp. 135-143
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?
Carlo Brogna, Barbara Brogna, Domenico Rocco Bisaccia, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 708-708
Open Access | Times Cited: 46
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes
Shanlin Ke, Scott T. Weiss, Yang‐Yu Liu
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
The nasopharyngeal microbiome in COVID-19
Sergio Candel, Sylwia D. Tyrkalska, Carmen Álvarez-Santacruz, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 32
NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy
Rosa Giugliano, Assunta Sellitto, Carlo Ferravante, et al.
Microbial Pathogenesis (2022) Vol. 165, pp. 105506-105506
Open Access | Times Cited: 26
Unravelling the gut-lung axis: insights into microbiome interactions and Traditional Indian Medicine's perspective on optimal health
Swati Haldar, Snehal Jadhav, Vandana Gulati, et al.
FEMS Microbiology Ecology (2023) Vol. 99, Iss. 10
Open Access | Times Cited: 13
Microbial metabolites: cause or consequence in gastrointestinal disease?
Serge A. T. Fobofou, Tor Savidge
AJP Gastrointestinal and Liver Physiology (2022) Vol. 322, Iss. 6, pp. G535-G552
Open Access | Times Cited: 22
Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study
Francesco Di Pierro, Somia Iqtadar, Sami Ullah Mumtaz, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1926-1926
Open Access | Times Cited: 17
Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals
Dinesh Kumar, Ramesh Pandit, Sonal Sharma, et al.
Microbial Pathogenesis (2022) Vol. 173, pp. 105829-105829
Open Access | Times Cited: 16
Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9
Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment
Min Jong Song, Dae Hun Kim, Su‐Young Kim, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
Taiping Zhu, Jun Jin, Minhua Chen, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 1076-1087
Open Access | Times Cited: 14
Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients
Eric C. Rouchka, Julia H. Chariker, Brian Alejandro, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
María Paz Ventero, Óscar Moreno, Carmen Molina-Pardines, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 329-336
Open Access | Times Cited: 18
Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia
Muhammad Yasir, Hessa A. Al-Sharif, Tagreed L. Alsubhi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 5, pp. 680-688
Open Access | Times Cited: 7
A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India
Tungadri Bose, Wasimuddin, Varnali Acharya, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Oxytocin, the panacea for long-COVID? a review
Phuoc-Tan Diep, Mohammed Chaudry, Adam Dixon, et al.
Hormone Molecular Biology and Clinical Investigation (2022) Vol. 43, Iss. 3, pp. 363-371
Open Access | Times Cited: 9
Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID-19 infection
Leonardo Mancabelli, Giuseppe Taurino, Andrea Ticinesi, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 5
Upper respiratory tract microbiome profiles in SARS-CoV-2 Delta and Omicron infected patients exhibit variant specific patterns and robust prediction of disease groups
Shankha Nath, Mousumi Poddar Sarkar, Ankita Maddheshiya, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 5
Human microbiota dysbiosis after SARS-CoV-2 infection have the potential to predict disease prognosis
Jie Zhou, Xiping Yang, Y. Yang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Modified Proline Metabolism and Prolidase Enzyme in COVID-19
Merve Ergin Tunçay, Salim Neşeli̇oğlu, Emra Asfuroğlu Kalkan, et al.
Laboratory Medicine (2022) Vol. 53, Iss. 5, pp. 453-458
Open Access | Times Cited: 8
Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID‐19 patients
Jiani Wu, Wei Liu, Lin Zhu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 4
Meta-analysis of the microbial biomarkers in the gut–lung crosstalk in COVID-19, community-acquired pneumonia and Clostridium difficile infections
S. Aishwarya, K. Gunasekaran
Letters in Applied Microbiology (2022) Vol. 75, Iss. 5, pp. 1293-1306
Open Access | Times Cited: 7
Understanding metabolic alterations after SARS-CoV-2 infection: insights from the patients’ oral microenvironmental metabolites
Shengli Ma, Lijun Yang, Hui Li, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Exploring the Pathoprofiles of SARS-COV-2 Infected Human Gut–Lungs Microbiome Crosstalks
Sisir Nandi, Sarfaraz Ahmed, Aaruni Saxena, et al.
(2023), pp. 217-235
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top